As spinal fusions require large volumes of bone graft, different bone graft substitutes are being investigated as alternatives. A subclass of calcium phosphate materials with submicron surface topography has been shown to be a highly effective bone graft substitute. In this work, a commercially available biphasic calcium phosphate (BCP) with submicron surface topography (MagnetOs; Kuros Biosciences BV) was evaluated in an Ovine model of instrumented posterolateral fusion. The material was implanted stand-alone, either as granules (BCP granules ) or as granules embedded within a fast-resorbing polymeric carrier (BCP putty ) and compared to autograft bone (AG). Twenty-five adult, female Merino sheep underwent posterolateral fusion at L2-3 and L4-5 levels with instrumentation. After 6, 12, and 26 weeks, outcomes were evaluated by manual palpation, range of motion (ROM) testing, micro-computed tomography, histology and histomorphometry. Fusion assessment by manual palpation 12 weeks after implantation revealed 100% fusion rates in all treatment groups. The three treatment groups showed a significant decrease in lateral bending at the fusion levels at 12 weeks (P < 0.05) and 26 weeks (P < 0.001) compared to the 6 week time-point. Flexion-extension and axial rotation were also reduced over time, but statistical significance was only reached in flexion-extension for AG and BCP putty between the 6 and 26 week time-points (P < 0.05). No significant differences in ROM were observed between the treatment groups at any of the time-points investigated. Histological assessment at 12 weeks showed fusion rates of 75%, 92%, and 83% for AG, BCP granules and BCP putty , respectively. The fusion rates were further increased 26 weeks postimplantation. Similar trends of bone growth were observed by histomorphometry. The fusion mass consisted of at least 55% bone for all treatment groups 26 weeks after implantation. These results suggest that this BCP with submicron surface topography, in granules or putty form, is a promising alternative to autograft for spinal fusion. 
, 3 bone graft substitutes are frequently employed to reduce or avoid morbidity related to the harvesting of autologous bone. 4 Calcium phosphate-based bone grafts have been widely investigated because of their excellent biocompatibility, osteoconductivity and controllable resorption rate. 5 A commonly addressed disadvantage compared to autologous bone is their lack of osteogenic and osteoinductive capacity. However, efforts to modify the physicochemical properties of calcium phosphates (ie, composition, porosity and, most recently, surface properties) have resulted in materials with bone-inducing properties. In particular, submicron surface topographies have been reported to enhance angiogenesis and bone healing properties following in vivo implantation. [5] [6] [7] [8] Surface properties of biomaterials have been shown to influence the phenotype of macrophages, [9] [10] [11] that are key modulators in the foreign body and wound healing responses. 12, 13 For promotion of bone repair, an increase in anti-inflammatory macrophages following an initial phase with pre-dominantly pro-inflammatory macrophages has been suggested to be important. 14, 15 Recently, calcium phosphates with submicron surface topography have been shown to promote the transition of macrophages to the pro-healing, anti-inflammatory M2 phenotype in vitro, 8 which has been linked to enhanced angiogenesis and superior bone healing properties observed with these materials. 6, 7 In the current study, a clinically relevant [16] [17] [18] Ovine model of instrumented PLF was used to compare treatment outcomes of a biphasic calcium phosphate (BCP) with submicron surface topography to bone autograft as a stand-alone treatment. The bone graft was implanted as granules alone and as a putty, with granules embedded in a fast-resorbing polymeric binder designed to improve handling properties. Study endpoints included fusion rate by manual palpation, range of motion (ROM), histology and histomorphometrical analysis of bone in the fusion mass after 6, 12 and 26 weeks.
| METHODS

| Calcium phosphate
Commercially available BCP bone graft (MagnetOs; Kuros Biosciences BV, Bilthoven, Utrecht, the Netherlands) was provided as granules (BCP granules ) and putty (BCP putty ). Both formulations contain 1 to 2 mm granules of bioactive bone graft comprising 65% to 75% TriCalcium Phosphate (TCP-Ca 3 (PO 4 ) 2 ) and 25% to 35% Hydroxyapatite (HA-Ca 10 (PO 4 ) 6 (OH) 2 ). The carrier in the putty formulation is a triblock copolymer synthesized from polyethylene glycol (PEG) and Llactide monomer. The resulting polymer is water-soluble and dissolves at near body temperature, leading to rapid dispersion after implantation (<48 hours). 19 Scanning electron microscopy (SEM; JSM 5600, JEOL) was used to characterize the submicron surface topography.
Bioactivity of the BCP surface was evaluated in vitro using the validated assay described by Kokubo et al. 20 Briefly, the materials were submerged in simulated body fluid (SBF) for 2, 4, 7, and 10 days and subsequently analyzed for presence of an apatite-like-layer using SEM. The materials for the animal study were provided sterile having been sterilized by gamma irradiation (25 kGy). BCP granules , and BCP putty , randomly allocated to the fusion levels (n = 5 for 6 and 26 weeks, n = 6 for 12 weeks). Postsurgery, the animals were housed at the laboratory animal facility where they were monitored and received proper postoperative care. After 6, 12, and 26 weeks, animals were euthanized by IV injection of Lethotarb (1 mL/2 kg i.v., 325 mg/mL) for analyses of endpoints.
| Animal study
| Manual palpation
After euthanasia, harvesting of the spines and removal of pedicle rods, the L2-L3 and L4-L5 segments were manually subjected to flexionextension (FE) and lateral bending (LB) to assess spine mobility. All levels were graded as either fused (low mobility), partially fused (one-sided mobility) and not fused (high mobility) under FE and LB. The fisher-Freeman-Halton Exact Test was performed for statistical analysis (P < 0.05).
| Micro-computed tomography
Micro-computed tomography (micro-CT) was performed using an Inveon Scanner (Siemens Medical Solutions USA, Inc., Knoxville, TN, USA) at a slice thickness of 50 μm.
| Biomechanical analysis
The treated levels were separately mounted on a robotic six degree of Simulation Solutions Ltd., Stockport, UK freedom musculoskeletal simulator, simVITRO (Simulation Solutions Ltd., Stockport, UK and Cleveland Clinic Biorobotics Lab, Cleveland, OH, USA). A 7.5 Nm pure moment was applied to the segments in FE, LB and axial rotation (AR).
Each loading profile was repeated three times for every specimen and the mean angular deformation was recorded. Data were analyzed with a two-factor ANOVA with a significance level of P < 0.05 using dedicated software (Graphpad version 5). Normal distribution of data was confirmed by Kolmogorov-Smirnov normality test.
| Histology and Histomorphometry
The treated spine levels were fixed in 4% phosphate-buffered formalin for 1 week at 4 Celsius. After fixation, samples were dehydrated through a series of increasing ethanol concentrations and were subsequently embedded in methylmethacrylate. A Leica SP1600 sawmicrotome was used to cut sagittal cross-sections (10-20 μm) from the region between TPs of each contralateral fusion mass. From each sample, three sections were obtained across the fusion mass for evaluation. Sections were stained with 1% methylene blue and 0.3% basic fuchsin to visualize bone tissue (bone matrix: pink, fibrous tissues: blue). Sections were visualized under a Leica microscope (Eclipse 50i, Nikon) for histological observation and were imaged using a slide scanner (DiMage scan 5400 Elite II, Konica Minolta, Tokyo, Japan) to obtain overviews for fusion assessment followed by histomorphometrical analysis. Each section was evaluated for histological fusion. Histological fusion was scored when a continuous presence of bone was observed between the TPs, connecting the adjacent spine segments.
From each fusion mass, the most representative section was used for histomorphometry. Histomorphometry of the fusion mass was per- 3 | RESULTS
| Material characterization
Surface structure analysis of the porous BCP granules ( Figure 1A )
by SEM demonstrated a surface topography of submicron-scale polygon crystals ( Figure 1B ). Average surface crystal diameter was determined to be 0.58 AE 0.21 μm. Surface mineralization, evident from the development of an apatite-like-layer of globules, was 
| Micro-computed tomography
Surgery and recovery proceeded without adverse events or adverse reactions to the implant materials. After 6, 12, and 26 weeks, animals were euthanized and the spine and surrounding tissues were harvested. Imaging by micro-CT showed that all graft materials were well-contained at the implantation sites and there was progression to a solid fusion mass between the spine segments over time (Figure 2 ).
At 26 weeks, mature fusion masses were evident and were indicated by incorporation of the graft materials with host bone, and the inability to discriminate individual BCP particles. Evaluation of fusion masses suggested higher fusion mass volumes in the BCP groups at 12 and 26 weeks than with AG, indicating higher graft volume stability with the BCP treatments.
| Manual palpation
Results of fusion assessment by palpation in a blinded manner are presented in Table 1 . The data indicate a 100% fusion rate in each group from 12 weeks onwards. No partially fused spines were found by manual palpation. No statistically significant differences in fusion between treatments at each time-point were determined (FisherFreeman-Halton exact test, P ≥ 0.5).
| Biomechanical evaluations
ROM testing was performed to determine whether treatment resulted in a reduction in mobility between the segments and thus a higher stability, which is the primary goal of spinal fusion. Results of ROM tests are presented in Figure 3 . These results show decreasing trends in ROM in LB, FE, and AR with no differences between treatment groups. The decrease was strongest in LB for all materials, with an average decrease of 5.50 AE 1.59 between 6 and FIGURE 2 Examples of transversal micro-CT slices of the treated spine levels for AG (A-C) and BCP (D-F) at 6 (A, D), 12 (B, E) and 26 (C, F) weeks. During time, consolidation of the fusion mass was evident for all treatments and gradual integration of graft materials with the underlying host bone was observed. Graft volume at 12 and 26 weeks appear higher for BCP treatments than for AG, suggesting a higher graft volume stability for BCP 
| Histology and histomorphometry
All further evaluations were performed by histology. Presence of a bony fusion between the segments was assessed on sagittal crosssections of the fusion mass, as presented in Figure 4 . The fusion scores are given in Table 2 . As the data show, fusion was rarely observed at 6 weeks. However, a steep increase was observed for all treatments at 12 weeks, with fusion rates of 75%, 92%, and 83% for Diagrams presenting ROM data of treated segments in LB (A), FE (B) and AR (C). Decrease in ROM over time was evident for each loading direction, with no significant differences between groups. Symbols: # significantly different from AG, 6 weeks (P < 0.05); † significantly different from BCP granules , 6 weeks (P < 0.01); ‡ significantly different from BCP putty , 6 weeks (P < 0.05); • all significantly different from 6 weeks (P < 0.001); ¤ significantly different from AG, 6 weeks (P < 0.01); § significantly different from BCP putty , 6 weeks (P < 0.05) FIGURE 4 Sagittal histological sections (basic fuchsin-methylene blue) of spine levels grafted with AG or BCP, taken from the region between the TP's. These sections were used to score spinal fusion, that is, the presence of a continuous bone bridge between the adjacent transverse processes. The 6 weeks sections shown on the left were scored as "not fused" whereas 12 and 26 weeks shown in the center and right side were scored as "fused". Histomorphometry data, represented in Figure 6 , are consistent with the general histological observation of the fusion mass. In all groups, the proportion of bone in the fusion mass steadily increased over time in a significant trend (P < 0.001), leading up to over 55% of bone after 26 weeks. Between groups, at the 6-week time-point, a higher proportion of bone was determined in the AG group (25.2% AE 5.0) compared to BCP granules (14.8% AE 7.1, P < 0.01) and BCP putty (10.8% AE 5.9, P < 0.001), which can be explained by the presence of autologous bone chips that were implanted at the fusion site. After healing periods of 12 and 26 weeks, no differences in bone volume were observed between all treatments (P > 0.05).
The proportion of BCP graft in the fusion mass was determined for BCP granules and BCP putty ( Figure 6 ) . As is evident from the graph, a decrease in material volume was determined over time. In both BCP groups, the amount of material in the fusion mass decreased by AE25%
in the healing period from 6 weeks to 26 weeks, which was confirmed by statistical analysis (P < 0.001 
| DISCUSSION
The posterolateral spine environment is known to be challenging for bone graft substitute materials because it provides very limited contact with host bone from which bone growth can progress. In fact, a successful lumbar arthrodesis is achieved by controlled bone TPs. 23 Because of this, materials with physicochemical properties designed to beneficially control the foreign body and wound healing responses may be more effective bone graft substitutes for PLF, as these can promote bone formation in sites distant from native bone through mechanisms other than osteoconduction alone.
Although most commercially available bone grafts have undergone testing in lapine posterolateral fusion studies, only a handful have been tested in higher-order animals such as sheep using posterior pedicle screws and rods. Wheeler et al. 24 compared BCP (Mastergraft; 15% HA/85% β-TCP) and autograft, and reported 57.1%
and 100% fusion respectively at 16 weeks. Bone proportion in the fusion mass at 16 weeks was significantly lower for the BCP (36.2% AE 3.95) than for autograft (55.1% AE 7.59). In another work, that studied macroporous BCP (MBCP; 65% HA/35% TCP), Guigui et al. 25 reported that this material achieved fusion after 12 months while fusion by autograft was already observed after 6 months, as was confirmed by biomechanical testing. A third study by Baramki et al. 26 reported high fusion rates for autograft and interconnected porous HA after 20 weeks, but mechanical tests revealed poorer outcomes for the HA group. In the absence of posterior fixation, β-TCP alone has also shown inferior performance to autograft. 27 Other studies have reported more favorable outcomes for ceramics compared to autograft in this model, [28] [29] [30] although certain limitations to those studies are evident when compared to the current work. First of all, fusion assessment by radiography (ie, X-ray and micro-CT) for evaluation of calcium phosphate grafts is inconclusive and may lead to overestimations, because the high radiopacity of calcium phosphate limits the ability to distinguish bone from material. [31] [32] [33] Since the formation of bone tissue is crucial for a successful spinal fusion, fusion assessment by histology is a more accurate and reliable indicator than radiographic assessment. Moreover, studies described in the prior art lacked internal references for mechanical testing (eg, multiple timepoints) and reported equivalent spinal fusion with autograft or ceramics at 16 weeks or later. Lastly, the age of the animal is often reported as "skeletally mature" rather than the specific age or age range. This is important, as fusion rates drop considerably for 5-yearold ewes 34 as compared to 2-3-year-old ewes, 35 . At 6 weeks, a slightly higher percentage of bone is shown for AG, but no differences were observed at later time-points. A decrease in material percentage during time was observed for both BCP treatments (B). A slight difference between BCP granules and BCP putty is apparent at 6 weeks and 26 weeks. Symbols: * P < 0.01; ** P < 0.001; # all significantly different from 6 weeks, P < 0.001; † all significantly different from 12 weeks and 6 weeks, P < 0.001; ‡ significantly different from BCP granules , 6 weeks, P < 0.01; • significantly different from BCP granules , 26 weeks, P < 0.05 evidence about the efficacy of calcium phosphate materials as bone graft materials for spine fusion. 36, 37 [9] [10] [11] and recently, calcium phosphates with a submicron surface topography were shown to promote the transition of macrophages to the M2 phenotype in vitro. 8 The upregulation of M2 macrophages by submicron structured calcium phosphates may explain the enhanced angiogenesis and superior bone healing properties observed with these materials in vivo, [6] [7] [8] as well as the results obtained in the current work. However, the techniques used in the current study to assess bone formation and spinal fusion were not designed for macrophage characterization. The proposed mechanism remains to be further experimentally verified in future studies.
A limitation of the current study is that no materials with different surface topographies were compared. Therefore, a recommendation for future studies in this model is to include materials with no surface topography or with surface topographies of different geometries and dimensions (ie, supermicron scale), in order to isolate the effect of material surface topography on graft efficacy. In addition, with regard to mechanical testing, inclusion of a sham or "empty" control (ie, no graft material) and baseline measurements immediately after surgery would provide more insight on the effect of spinal fusion by these graft materials on spine ROM.
We may conclude that this study provides solid evidence of the adequate performance of a BCP with tailored physicochemistry as stand-alone alternative to autograft in a clinically relevant Ovine model of PLF. By application of reliable fusion assessment by histology and supporting analyses at relevant time-points, we demonstrated a high fusion rate after 12 weeks for this material, with overall equivalence to autograft in fusion rate, mechanical integrity and bone formation over the entire healing period of 26 weeks. These findings support the premise that calcium phosphates with a submicron surface topography are highly effective bone graft substitutes for PLF and this justifies further clinical investigation of these materials.
